Eurazeo has entered into exclusive negotiations to sell its stake in pharmaceutical and specialty ingredients producer Seqens to SK Capital, as well the company’s existing shareholders, which include Ardian.
GP plans to acquire a majority stake in the business, according to a competition authority filing
New GP specialising in healthcare has already deployed 65% of the fund's target
Decision made to halt an initial public offering as a result of volatile market conditions
Sweden-based technology investor has been listed on the Swedish stock exchange since 1997